Grove Bank & Trust

Bank

Position in NVS — Novartis AG

CIK 1662212 Miami, FL

Position in NVS

as of Jun 30, 2026 · filed Jul 7, 2026 Compact

Position Value

$583,311

-$9,817 QoQ

Shares Held

3,722

-4.1% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.14%

of 13F equity value

Holder Rank

#826

of 1,603 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 15% Shared 0% None 85%

Healthcare · as of Jun 30, 2026

Grove Bank & Trust holds $25,083,993 across 15 Drug Manufacturers - General names. NVS ranks #9 (2.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	7,571	$9,080,885
2	ABBV	AbbVie Inc.	15,353	$3,863,428
3	JNJ	Johnson & Johnson	15,184	$3,856,280
4	MRK	Merck & Co., Inc.	15,556	$1,998,945
5	BMY	Bristol Myers Squibb Co	22,434	$1,292,646
6	AMGN	Amgen Inc	3,253	$1,177,976
7	AZN	Astrazeneca PLC	5,776	$1,095,244
8	GILD	Gilead Sciences, Inc.	6,271	$792,278

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$583,311	3,722	-4.1%	Shares	Sole	2026-07-07
2026-03-31	$593,128	3,883	+24.3%	Shares	Sole	2026-04-08
2025-12-31	$430,705	3,124	+315.4%	Shares	Sole	2026-01-08
2025-09-30	$96,436	752	-26.1%	Shares	Sole	2025-10-06
2025-06-30	$123,188	1,018	+1.3%	Shares	Sole	2025-07-11
2025-03-31	$112,037	1,005	-3.9%	Shares	Sole	2025-04-17
2024-12-31	$101,786	1,046	-14.5%	Shares	Sole	2025-01-16
2024-09-30	$140,669	1,223	+37.3%	Shares	Sole	2024-10-11
2024-06-30	$94,855	891	-2.1%	Shares	Sole	2024-07-24
2024-03-31	$88,024	910	+1.7%	Shares	Sole	2024-04-30
2023-12-31	$90,368	895	-0.4%	Shares	Sole	2024-01-30
2023-09-30	$91,572	899	-4.8%	Shares	Sole	2023-10-30
2023-06-30	$95,259	944	-0.5%	Shares	Sole	2023-07-27
2023-03-31	$87,308	949	+3.8%	Shares	Sole	2023-05-10
2022-12-31	$82,918	914	—	Shares	Sole	2023-02-03
No filing history on record for this holder in this stock.